Ładuje się......
Product review on the Anti-PD-L1 antibody atezolizumab
Immunotherapy as a therapeutic strategy has seized the narrative throughout clinical oncology over the past few years. Once considered a niche treatment for rare cancers, immunotherapy has quickly emerged as the standard of care for many common cancer types. The remarkable rise is largely due to the...
Zapisane w:
| Wydane w: | Hum Vaccin Immunother |
|---|---|
| Główni autorzy: | , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Taylor & Francis
2017
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5806639/ https://ncbi.nlm.nih.gov/pubmed/29194007 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2017.1403694 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|